Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-23-001623
Filing Date
2023-08-17
Accepted
2023-08-17 14:07:32
Documents
53
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 10-Q SEC FILING tpia-20230630.htm   iXBRL 10-Q 474475
2 CERTIFICATION tpia_ex31z1.htm EX-31.1 8443
3 CERTIFICATION tpia_ex32z1.htm EX-32.1 4313
  Complete submission text file 0001096906-23-001623.txt   2778545

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20230630_cal.xml EX-101.CAL 17893
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20230630_def.xml EX-101.DEF 62641
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20230630_lab.xml EX-101.LAB 148289
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20230630_pre.xml EX-101.PRE 133221
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20230630.xsd EX-101.SCH 30674
47 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20230630_htm.xml XML 399423
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56022 | Film No.: 231181165
SIC: 2833 Medicinal Chemicals & Botanical Products